Back to Resource Center

Medicines Patent Pool: Licenses

Medicines Patent Pool: Licenses

To date, Medicines Patent Pool has signed agreements with 15 patent holders for 13 HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals, a tuberculosis treatment, two long-acting technologies, two experimental oral antiviral treatments for COVID-19 and 12 COVID-19 technologies.

June 2022

Click to view Webpage

Click for full info +

Medicines Patent Pool: Licenses

June 2022
In this Technical Brief:
Product Type(s):

  • Long-Acting Therapeutics
Topic(s):

  • Licenses
Region(s):

  • United States, L/MICs

Full Info:


Resource Type:

Webpage

Citation:

Medicines Patent Pool

Authors: Lobna Gaayeb, Long-Acting Technologies Project Manager

Health Risks(s):

  • Hepatitis
  • HIV
  • Malaria

Product type(s):

  • Injectables
  • MPTs

Topic(s):

  • MPTs
  • Development
  • Trials

Region(s)

  • Global

URL of resource:

https://medicinespatentpool.org/progress-achievements/licences

Back to Resource Center